Clinical Trial Update: Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck [Phase 2]

View source ↗

Summary

This Phase 2 trial update reports the results of combining docetaxel with vandetanib (Zactima) in locally advanced squamous cell carcinoma of the head and neck.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Taxotere (docetaxel)
• Zactima (vandetanib)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 2 | Status: COMPLETED | Results posted: 2013-07-03